Skip to main content
. 2022 Apr 6;13:846124. doi: 10.3389/fendo.2022.846124

Table 1.

Descriptive characteristics of the 10 patients.

Characteristic N
Female gender 40.0% 4/10
Age at diagnosis, years, median (IQR) 1.46 0.58–3.31
Age at follow-up, years, median (IQR) 9.74 5.81–11.25
Follow-up time, years, median (IQR) 8.10 4.63–9.42
Histology
– Pilocytic astrocytoma 70.0% 7/10
No information available 30.0% 3/10
NF 1 30.0% 3/10
Metastases at diagnosis 20.0% 2/10
Hydrocephalus 40.0% 4/10
Endocrine disorder at diagnosis 0.0% 0/10
Relapse 80.0% 8/10
Surgery 60.0% 6/10
Number of tumor surgeries, median (range) 1 0–5
Chemotherapy 90.0% 9/10
Rounds of chemotherapy, median (range) 2 0–7
Radiotherapy 0.0% 0/10
State of disease at follow-up
– Stable residual disease 70.0% 7/10
– Progressive disease but clinically well 30.0% 3/10